Alberto Mantovani Selected Research

Pattern Recognition Receptors

1/2021	The tetraspan MS4A family in homeostasis, immunity, and disease.
1/2021	Complementary Roles of Short and Long Pentraxins in the Complement-Mediated Immune Response to Aspergillus fumigatus Infections.
1/2019	PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
11/2014	Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.
1/2012	Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia.
6/2009	The long pentraxin 3 is a soluble and cell-associated component of the human semen.
3/2009	Pentraxins: multifunctional proteins at the interface of innate immunity and inflammation.
1/2008	Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.
11/2007	Macrophage receptors implicated in the "adaptive" form of innate immunity.
11/2006	The long pentraxin PTX3 in vascular pathology.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto Mantovani Research Topics

Disease

131	Inflammation (Inflammations) 11/2022 - 05/2002
104	Neoplasms (Cancer) 11/2022 - 07/2002
30	Infections 03/2022 - 10/2002
15	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2002
14	COVID-19 03/2022 - 01/2021
11	Carcinogenesis 07/2018 - 07/2007
8	Body Weight (Weight, Body) 01/2022 - 09/2014
7	Fibrosis (Cirrhosis) 01/2021 - 04/2011
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 05/2002
7	Myocardial Infarction 01/2012 - 07/2004
6	Fever (Fevers) 03/2022 - 08/2007
6	Adenocarcinoma 06/2021 - 11/2004
6	Sepsis (Septicemia) 05/2021 - 10/2002
5	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022 - 11/2004
5	Rheumatoid Arthritis 01/2021 - 06/2007
5	Obesity 11/2019 - 05/2003
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 06/2002
5	Pneumonia (Pneumonitis) 01/2018 - 10/2010
5	Thrombosis (Thrombus) 01/2017 - 05/2002
5	Hypoxia (Hypoxemia) 02/2013 - 07/2002
5	Heart Failure 01/2013 - 10/2004
4	Atherosclerosis 10/2022 - 07/2004
4	Fibrosarcoma 10/2021 - 03/2006
4	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 03/2006
4	Giant Cell Arteritis (Horton Disease) 03/2020 - 01/2012
4	Melanoma (Melanoma, Malignant) 01/2019 - 07/2006
4	Colorectal Neoplasms (Colorectal Cancer) 07/2018 - 04/2014
4	Coccidiosis 07/2018 - 12/2017
4	Colitis 01/2017 - 02/2010
4	Colonic Neoplasms (Colon Cancer) 08/2016 - 01/2009
4	Acquired Immunodeficiency Syndrome (AIDS) 03/2016 - 07/2008
4	Necrosis 11/2015 - 06/2003
4	Acute-Phase Reaction 01/2012 - 08/2004
3	Anosmia 01/2022 - 01/2021
3	Lung Neoplasms (Lung Cancer) 01/2021 - 02/2016
3	Bacterial Infections (Bacterial Infection) 01/2021 - 08/2005
3	Takayasu Arteritis (Arteritis, Takayasu's) 03/2020 - 11/2014
3	Heart Diseases (Heart Disease) 01/2020 - 02/2008
3	Lung Injury 01/2020 - 08/2008
3	Congenital Abnormalities (Deformity) 11/2019 - 07/2007
3	Septic Shock (Toxic Shock Syndrome) 01/2017 - 07/2004

Drug/Important Bio-Agent (IBA)

46	PTX3 proteinIBA 11/2022 - 02/2003
46	CytokinesIBA 10/2021 - 07/2002
43	ChemokinesIBA 01/2022 - 07/2002
22	Complement System Proteins (Complement)IBA 11/2022 - 06/2002
22	Biomarkers (Surrogate Marker)IBA 05/2022 - 10/2004
21	Proteins (Proteins, Gene)FDA Link 05/2022 - 05/2002
16	Pattern Recognition ReceptorsIBA 01/2021 - 07/2004
14	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2022 - 03/2003
14	Interleukin-1 (Interleukin 1)IBA 01/2021 - 10/2002
14	C-Reactive ProteinIBA 01/2017 - 05/2002
13	Chemokine ReceptorsIBA 01/2018 - 11/2003
12	AntibodiesIBA 01/2022 - 03/2010
12	LigandsIBA 01/2019 - 11/2003
9	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 08/2010
8	Messenger RNA (mRNA)IBA 01/2022 - 06/2007
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2021 - 05/2003
8	Acute-Phase Proteins (Acute-Phase Protein)IBA 04/2020 - 02/2003
8	Interleukin-6 (Interleukin 6)IBA 01/2018 - 03/2003
7	VaccinesIBA 03/2022 - 02/2008
7	Hormones (Hormone)IBA 01/2011 - 10/2002
6	Biological ProductsIBA 01/2022 - 07/2010
6	Antiviral Agents (Antivirals)IBA 12/2019 - 03/2008
5	Immunoglobulin G (IgG)IBA 03/2022 - 01/2016
5	MicroRNAs (MicroRNA)IBA 10/2021 - 03/2009
5	Scavenger Receptors (Scavenger Receptor)IBA 11/2016 - 05/2005
5	Transcription Factors (Transcription Factor)IBA 08/2016 - 11/2005
4	RNA (Ribonucleic Acid)IBA 03/2022 - 01/2009
4	Testosterone (Sustanon)FDA Link 04/2021 - 03/2015
4	FibrinIBA 01/2021 - 05/2002
4	Indicators and Reagents (Reagents)IBA 01/2021 - 08/2005
4	CC ChemokinesIBA 01/2018 - 02/2007
4	Immunoglobulins (Immunoglobulin)IBA 11/2017 - 04/2010
4	LipidsIBA 01/2017 - 02/2008
4	Interleukin-10 (Interleukin 10)IBA 01/2017 - 12/2006
4	InterleukinsIBA 01/2017 - 10/2002
4	EnzymesIBA 07/2016 - 10/2005
4	AutoantibodiesIBA 01/2016 - 02/2007
4	Chemokine Receptor D6IBA 01/2016 - 01/2013
4	TrabectedinIBA 01/2015 - 03/2010
4	Oxygen (Dioxygen)IBA 02/2013 - 07/2002
3	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2017
3	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022 - 07/2015
3	Conditioned Culture MediaIBA 10/2021 - 07/2010
3	Interleukin-8 (Interleukin 8)IBA 09/2021 - 06/2009
3	COVID-19 VaccinesIBA 06/2021 - 01/2021
3	Imiquimod (Aldara)FDA LinkGeneric 01/2021 - 09/2013
3	Pharmaceutical PreparationsIBA 01/2021 - 11/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2020 - 03/2010
3	Interleukin-17 (Interleukin 17)IBA 01/2018 - 09/2013
3	IronIBA 02/2017 - 02/2008
3	Therapeutic UsesIBA 01/2017 - 05/2011
3	Endocrine DisruptorsIBA 01/2017 - 07/2015
3	Chemokine CX3CL1IBA 01/2016 - 02/2010
3	Collectins (Collectin)IBA 01/2016 - 11/2004
3	Amyloid (Amyloid Fibrils)IBA 01/2016 - 01/2009
3	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2016 - 11/2004

Therapy/Procedure

29	Therapeutics 01/2022 - 04/2006
10	Immunotherapy 11/2022 - 01/2015
5	Drug Therapy (Chemotherapy) 01/2020 - 09/2013